News | May 06, 2023
Ajanta pharma posts Q4FY23 consolidated PAT at Rs. 122.25 Cr
The company has reported total income of Rs. 918.67 crores during the period ended March 31, 2023
The company has reported total income of Rs. 918.67 crores during the period ended March 31, 2023
The collaboration between CORONA and Ferring will cater to patients across India
PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
New agreement applies to the polymers of the Medical Care series portfolio
The committee voted that FDA should restrict use of LYNPARZA plus abi/pred to these BRCAm mCRPC patients
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
Subscribe To Our Newsletter & Stay Updated
